MolecuLight^®enhances
Sampling & Antimicrobial Stewardship

Fluorescence imaging provided objective and actionable information at the bedside, reducing the frequency of systemic antibiotic prescriptions by 4.6 times.

Fluorescence imaging objectively guided clinicians to bacterial hotspots, yielding higher bacterial loads and more reliable microbial profiles.

This study introduced a novel point-of-case diagnostic technique, the “C-Swab” test, which uses a sterile cotton applicator, in combination with fluorescence imaging, to detect hidden bacteria deep within wounds that can be missed by standard assessment for proactive bacterial management.

MolecuLight-targeted sampling demonstrated superior accuracy versus Levine swabbing in detecting high bacterial loads, also identifying a greater diversity of bacterial species within wounds.

Fluorescence imaging provided actionable insights on bacterial burden, enabling informed and localized treatment decisions that reduced antibiotic overuse.

MolecuLight imaging enhanced communication and collaboration between wound care teams, leading to improved assessment accuracy and standardized treatment interventions.